Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress RLAY Q1 2026 Earnings EPS Misses Consensus PreRevenue Biotech Maintains RD Focus KRP Q1 2026 Earnings Steep Earnings Miss Amid Challenging Environment OPLN Q1 2026 Earnings EPS Surpasses Estimates with 1243 Beat Radian Group Q1 2026 Earnings EPS Surpasses Expectations Despite Market Headwinds PHVS Q1 2026 Earnings NarrowerthanExpected Loss Despite No Revenue Stock Down